Institutionelle bei Abgenix

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Taunus Corporation 3,341,821 $28,438,896
JP Morgan Chase & Company 3,034,557 $25,824,080
Price (T.Rowe) Associates 2,997,269 $25,506,759
Franklin Resources, Inc 2,889,950 $24,593,474
Orbimed Advisors Inc. 2,826,500 $24,053,515
Wellington Management Company 1,963,800 $16,711,938
Deerfield Management 1,930,000 $16,424,300
Pequot Capital Management, Inc. 1,843,000 $15,683,930
FMR Corporation (Fidelity Management & Research Corp) 12,918,402 $109,935,601
Brinson Partners, Inc. 1,687,650 $14,361,901

Topliste der investierten Fonds
Fidelity Growth Company Fund 4,406,200 $37,496,762
Fidelity Aggressive Growth Fund 2,199,500 $18,717,745
Fidelity Select Portfolios - Biotechnology 1,974,100 $16,799,591
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 1,606,960 $13,675,229
Eaton Vance Global Health Portfolio 1,600,000 $13,616,000
Franklin Strategic Series-Franklin Small-Mid Cap Growth Fd 1,181,000 $10,050,310
Variable Insurance Products Fd-Growth Portfolio 1,181,842 $10,057,475
Finex Fonds Bio Spezial 1,100,000 $9,361,000
Fidelity Advisor Equity Growth Fund 1,077,000 $9,165,270
Putnam Vista Fund 1,082,500 $9,212,075